Skip to main content

Table 3 Results of the outlet census and anti-malarial audit by country and survey year

From: What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism

Country Year Screened (N) Outlets the met screening criteria Anti-malarial audit complete (N) Anti-malarials audited (N) QA ACT audited (N)
West & Central Africa
 Nigeria 2009 5456 2210 2113 20,841 1192
2011 7938 1567 1486 13,391 2119
2013 5148 1828 1714 14,358 4799
2015 13,483 3624 3473 33,532 9581
East Africa
 Kenya 2010 13,897 2625 1888 8376 2052
2011 11,383 2112 1854 9544 3669
2014 12,676 2477 2133 9899 3234
 Tanzania 2010 3120 710 624 5544 416
2011 3702 799 787 9701 2045
2014 4724 2160 2129 17,307 4905
 Uganda 2010 11,153 2590 2410 14,427 2893
2011 16,207 3285 3138 20,283 5495
2013 7932 3504 3307 19,777 7182
2015 9438 4780 4328 26,640 7380
Southern Africa
 Madagascar 2010 6769 2642 2414 5579 1790
2011 10,046 2854 2360 7234 3233
2013 10,149 2021 1756 6101 3851
2015  13,481 1361  1040  3170 1501